지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한생식의학회 Clinical and experimental reproductive medicine : CERM Clinical and experimental reproductive medicine : CERM 제44권 제2호
- 발행연도
- 2017.1
- 수록면
- 57 - 62 (6page)
이용수
초록· 키워드
오류제보하기
The purpose of this paper is to assimilate all data pertaining to the use of gonadotropin-releasing hormone (GnRH) antagonists in in vitro fertilization cycles after ovulation trigger to reduce the symptoms of ovarian hyperstimulation syndrome (OHSS). A systematic review of the literature was performed to identify all studies performed on the use of a GnRH antagonist in IVF cycle post-ovulation trigger with patients at high risk for OHSS. Ten studies were identified and reviewed. Descriptions of the studies and their individual results are presented in the following manuscript. Due to significant heterogeneity among the studies, it was not possible to perform a group analysis. The use of GnRH antagonists post-ovulation trigger for treatment of OHSS has been considered for almost 20 years, though research into its use is sparse. Definitive conclusions and recommendations cannot be made at this time, though preliminary data from these trials demonstrate the potential for GnRH antagonists to play a role in the treatment of OHSS in certain patient populations.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Gonadotropin releasing hormone antagonist administration for treatment of early type severe ovarian hyperstimulation syndrome: a case series
Obstetrics & Gynecology Science
2017 .01
-
Early gonadotropin-releasing hormone antagonist protocol in women with polycystic ovary syndrome: A preliminary randomized trial
Clinical and experimental reproductive medicine : CERM
2018 .01
-
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
Obstetrics & Gynecology Science
2021 .01
-
Preterm Ovarian Hyperstimulation Syndrome
Neonatal medicine
2015 .01
-
Efficacy of corifollitropin alfa followed by recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist protocol for Korean women undergoing assisted reproduction
Clinical and experimental reproductive medicine : CERM
2015 .01
-
Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles
Clinical and experimental reproductive medicine : CERM
2015 .01
-
Gonadotropin-releasing hormone stimulation test and diagnostic cutoff in precocious puberty: a mini review
Annals of Pediatirc Endocrinology & Metabolism
2020 .01
-
The Risk Factors and Pregnancy Outcomes of 48 Cases of Heterotopic Pregnancy from a Single Center
Journal of Korean Medical Science
2016 .01
-
Oncology Efficacy of Gonadotropin-Releasing Hormone Agonist in Hormone Receptor-Positive Very Young Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
대한외과학회 학술대회 초록집
2018 .11
-
A high response to controlled ovarian stimulation induces premature luteinization with a negative impact on pregnancy outcomes in a gonadotropin-releasing hormone antagonist cycle
Clinical and experimental reproductive medicine : CERM
2015 .01
-
Serum Cholesterol Level Changes during Gonadotropin-Releasing Hormone-Agonist Therapy in Premenopausal Female Patients with Breast Cancer
대한폐경학회지
2024 .08
-
Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
Annals of Dermatology
2019 .01
-
Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
Obstetrics & Gynecology Science
2022 .03
-
Evaluation of infertility efficacy of the E. coli expressed STF2-GnRH vaccine in male cats
Journal of Veterinary Science
2019 .05
-
The meaning of anti-Mullerian hormone levels in patients at a high risk of poor ovarian response
Clinical and experimental reproductive medicine : CERM
2016 .01
-
Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?
Annals of Surgical Treatment and Research
2023 .07
-
Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients
Journal of Breast Cancer
2015 .01
-
Evaluation of immunocontraceptive vaccine composed of gonadotropin-releasing hormone conjugated with granulocyte-macrophage colony-stimulating factor in male rats
Korean Journal of Veterinary Research(대한수의학회지)
2017 .11
-
GnRH signaling in aging and stress physiology
한국실험동물학회 학술발표대회 논문집
2025 .02
-
Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist
Obstetrics & Gynecology Science
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0